Find clinical documentation and medical coding resources for Exposure to Venereal Disease, also known as Exposure to Sexually Transmitted Infections or Contact with STIs. This page offers information on diagnosis codes, healthcare guidelines, and best practices for documenting exposure to STDs and STIs in patient records. Learn about relevant medical terminology and improve the accuracy of your clinical documentation for optimal patient care and billing.
Also known as
Contact with and suspected exposure to...
Contact with and suspected exposure to other infectious and parasitic diseases.
Syphilis and other treponemal infections
Encompasses various stages and manifestations of syphilis.
Gonococcal infection
Covers infections caused by Neisseria gonorrhoeae, including various sites.
Viral infections characterized by skin and...
Includes viral diseases like herpes, predominantly affecting skin and mucous membranes.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the exposure confirmed?
When to use each related code
| Description |
|---|
| Exposure to STIs |
| Syphilis infection |
| Chlamydia infection |
Coding lacks specificity. Document the specific STI for accurate reporting and reimbursement.
Differentiate between exposure and confirmed infection. Incorrect coding impacts public health data.
Incomplete documentation of contact tracing efforts may lead to compliance issues and hinder disease control.
Q: What are the most effective strategies for post-exposure prophylaxis (PEP) following suspected exposure to syphilis, gonorrhea, or chlamydia?
A: Post-exposure prophylaxis (PEP) can significantly reduce the risk of developing syphilis, gonorrhea, or chlamydia following a potential exposure. For syphilis, a single intramuscular injection of benzathine penicillin G is usually sufficient. For gonorrhea, current CDC guidelines recommend ceftriaxone intramuscularly along with oral azithromycin. Chlamydia PEP typically involves a single dose of oral azithromycin or a 7-day course of doxycycline. It's crucial to accurately identify the specific STI and tailor the PEP regimen accordingly, emphasizing that PEP does not cover all STIs. Consider implementing routine STI screening alongside PEP for comprehensive patient care. Explore how rapid diagnostic tests can be utilized for prompt and effective management of suspected exposures. Learn more about CDC guidelines for STI treatment and prevention.
Q: How do I differentiate between the symptoms of early-stage syphilis, herpes, and chancroid in a patient reporting potential exposure to venereal disease?
A: Differentiating between early-stage syphilis, herpes, and chancroid can be challenging due to overlapping symptoms. Syphilis typically presents with a painless chancre, while herpes lesions are painful vesicles or ulcers. Chancroid often manifests as painful genital ulcers with a ragged border and may be accompanied by painful inguinal lymphadenopathy. Accurate diagnosis requires a thorough clinical evaluation, including darkfield microscopy for syphilis, viral culture or PCR for herpes, and culture or PCR for Haemophilus ducreyi, the causative agent of chancroid. It's essential to consider the patient's sexual history and conduct appropriate testing to guide treatment. Explore how diagnostic algorithms can aid in differentiating these infections. Consider implementing a comprehensive sexual health history-taking approach for accurate risk assessment. Learn more about the nuances of genital ulcer disease diagnosis and management.
Patient presents with concerns regarding potential exposure to a sexually transmitted infection (STI), also referred to as a venereal disease (VD). The patient reports [specific type of exposure, e.g., unprotected sexual intercourse, sexual contact with an individual diagnosed with an STI, sharing needles]. The date of the potential exposure is [date of exposure]. The patient's partner's STI status is [known/unknown]. The patient is [symptomatic/asymptomatic]. If symptomatic, describe specific symptoms, e.g., The patient reports [symptoms such as genital discharge, burning during urination, genital lesions, pelvic pain]. Relevant medical history includes [past STIs, current medications, allergies]. A physical examination [was/was not] performed, and findings include [detailed findings]. Differential diagnoses considered include [list of potential STIs and other relevant conditions]. Based on the patient's history and presentation, the assessment is exposure to a sexually transmitted infection. Plan includes [STI testing for gonorrhea, chlamydia, syphilis, HIV, herpes, HPV, hepatitis B and C as appropriate; prophylactic treatment if indicated; counseling on safe sex practices; partner notification and treatment; follow-up appointment scheduled for [date]]. Patient education provided regarding STI transmission, prevention, and the importance of treatment adherence. ICD-10 code Z20.821 (contact with and suspected exposure to other sexually transmitted diseases) is considered. Further evaluation and treatment will be based on STI testing results.